Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
149 Leser
Artikel bewerten:
(0)

Morehouse School of Medicine Mourns the Loss of Senator Arlen Specter

ATLANTA, Oct. 16, 2012 /PRNewswire/ --Morehouse School of Medicine (MSM) was deeply saddened to learn of the passing of former U. S. Senator Arlen Specter (D-PA). Senator Specter was a consummate champion of justice and worked tirelessly throughout his career to reduce health and healthcare inequities. He also worked diligently to ensure that there were opportunities for individuals from minority communities and disadvantaged backgrounds to pursue a career in the health professions.

Morehouse School of Medicine President, John E. Maupin, Jr., D.D.S., said, "We very much appreciated Senator Specter's leadership in working with his Senate colleagues to support federal initiatives that enhanced health profession training opportunities for minority students and strengthened the research infrastructure of centers of emerging excellence like Morehouse School of Medicine. He will be sorely missed. The entire Morehouse School of Medicine family extends our deepest sympathy to his family."

During his time in the United States Senate, Specter played a key role in providing federal funding for Morehouse School of Medicine's National Center for Primary Care, a nationally renowned center advancing the value of primary care health services. As chairman of the Senate Health Appropriations Subcommittee, Senator Specter was instrumental in bringing attention to identified shortfalls in the National Institute of Health's (NIH) efforts to investigate the causes and cures of ethnic based health disparities. His efforts led to the introduction and ultimate passage of legislation that created the National Institute on Minority Health and Health Disparities (NIMHD) at NIH.

About Morehouse School of Medicine
Morehouse School of Medicine is one the nation's most widely recognized community-based medical schools. The institution's mission places special emphasis on primary care training; development of model community-based health services and the conduct of research and translation of discovery to benefit vulnerable populations and ultimately eliminate health inequities.

The School offers doctoral programs in medicine and biomedical research; and Master of Science degree programs in public health and clinical investigation. It also sponsors graduate training (residency) programs in family medicine, internal medicine, obstetrics and gynecology, pediatrics, psychiatry, public health and preventive medicine, and general surgery.

Morehouse School of Medicine annually ranks as one of the top U.S. medical schools in the percentage of graduates practicing primary care specialties. The School ranks # 1 in the first-ever study of all U.S. medical schools in the area of social mission. Such recognition underscores the vital role that MSM plays in the nation's health care system.

Morehouse School of Medicine is accredited by the Liaison Committee on Medical Education, and the Southern Association of Colleges and Schools. It is also a member of the Atlanta University Center Consortium, the world's oldest and largest association of historically black colleges and universities. For more information about Morehouse School of Medicine, visit us online at www.msm.edu.

SOURCEMorehouse School of Medicine

© 2012 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.